ProblemsOperational Excellence Consulting › Healthcare Providers

Operational Excellence Consulting
in Healthcare Providers

Programmes spread effort across every team yet leave cost per episode under the value-based contracts unchanged because the teams handling the 38,000 attributed lives already work at full load. What makes this harder for healthcare providers is structural: downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. Any credible answer therefore has to hold cost per episode and payer mix in the same view, which is exactly where most internal analysis stops because the two live in different systems.

The short answer

Programmes spread effort across every team yet leave cost per episode under the value-based contracts unchanged because the teams handling the 38,000 attributed lives already work at full load. What makes this harder for healthcare providers is structural: downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. Any credible answer therefore has to hold cost per episode and payer mix in the same view, which is exactly where most internal analysis stops because the two live in different systems.

One element at any time caps the contribution earned from the attributed lives, whether a provider panel, an approval step, or the handling of high-cost episodes. Activity outside that element adds to unprocessed cases or documentation volume without lifting revenue from the contracts. Projects arise from groups that have spare hours, so the loaded providers or the cost data gap never become the focus.

The result is measurable activity that leaves payer mix and contract performance flat. Standard work and visible boards appear in areas that do not touch episode cost, while the contribution per provider stays the same. Additional projects then consume still more time from the groups that were never the limit.

The step that sets contribution per provider often contains the wrong cases because payer mix and episode selection have not been reviewed. Refining methods there only reduces the cost of work that continues to erode margin under the contracts.

Efficiency Transformation Strategy (catalog id T12) begins with the element that determines cost per episode and contribution per provider for the attributed lives, then states what must change for any added capacity to improve contract results. Where the limit is genuinely process speed, a lean programme follows from that diagnosis and is aimed only at the identified point.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Completed projects accumulate while cost per episode and margins on the value-based contracts show no movement.
✓ Medical director and CFO name different steps as the one that controls panel economics or episode cost.
✓ The largest reported gains in throughput or documentation occur in teams that already had available provider or staff time.

The move that usually makes it worse. Rolling a standard method across every team, which spends the scarce project capacity on steps that never set cost per episode or contribution per provider.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and a large number of completed improvement initiatives and unchanged output. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

Excerpt from a real Percision run · Quick Market Scan · sample company profile

The move. Turn $6.8 M downside-risk liability into a $22–35 M licensing platform within 36 months.

The leak it closes. Eliminates $6.8 M downside exposure by enabling proactive utilization management.

The assumption it rests on. Cost-measurement platform achieves <5 % variance versus manual abstraction within 12 months — the engine put the probability at 0.75.

What the run committed to
Investment required$2.1–3.5 M over 36 months
Expected return6.3–16.7× cash-on-cash within 36 months based on $196 M current revenue base.
Revenue, year 1$0 licensing revenue; $1.8 M internal cost avoidance
Revenue, year 2$4.2 M licensing ARR (40 physicians × $120K + 5 external practices × $400K)
Revenue, year 3$13.5 M licensing ARR (90 physicians × $120K + 18 external practices × $400K) plus $4–8 M shared-savings upside
Exit criteriaTerminate platform investment if variance exceeds 8 % by Month 18 OR if fewer than 40 physicians sign licensing agreements by Month 24; redeploy remaining capital to ASC surgeon-retention track.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Efficiency Transformation Strategy, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

Is lean or six sigma the better method?

They solve different problems and the choice matters less than the aim. Lean attacks flow and waiting; six sigma attacks variation and defects. If your problem is that things sit in queues, lean. If it is that outputs are inconsistent, six sigma. If you do not yet know which, the method choice is premature and either one will produce activity.

What does an operational excellence programme cost?

Assessment phases run roughly £40k–£120k. Full deployment with embedded practitioners and training is commonly £250k–£1m over a year, often quoted against a promised multiple of savings. Ask how the baseline is set and who verifies the savings, because self-verified benefits are the norm and they are systematically generous.

Can this be done without consultants?

The method can — the material is public and cheap, and plenty of firms have taught themselves. What is genuinely hard to self-supply is the outside judgement about where to aim it and the willingness to say that a favoured department is not the problem. That is the part worth buying, and it is a much smaller purchase than a deployment.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

Is this what is happening in your business?

Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.

Describe my situation →

Prefer to skip ahead? Go straight to the free diagnostic.

English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית